Researchers at Georgia Tech have developed a lateral flow test platform that can perform advanced assays that would otherwise require a laboratory. By controlling the flow of liquid through the ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. Published in Cell Reports Medicine, a team of researchers from the ...

Point-of-care diagnostics similar to home COVID-19 tests were able to detect microbial keratitis (MK) caused by Aspergillus fungus with good accuracy, according to a prospective study. An ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...

Abingdon Health are pleased to announce the CE marking and FDA registration of their newly available immunoassay reader - ADxLR5® as a Class 1 Medical Device. The ADxLR5® lateral flow device reader ...

OULU, Finland--(BUSINESS WIRE)--Ginolis Ltd, a leading provider of high precision liquid handling and intelligent desktop automation for MedTech industries, today announced the launch of the ...

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...

Lateral flow devices, or lateral flow tests, have played a significant role in helping to identify infectious individuals during the coronavirus disease 2019 (COVID-19) pandemic. They have been key ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...